These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33581505)

  • 1. Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
    Parag-Sharma K; Tasoulas J; Musicant AM; do Nascimento-Filho CHV; Zhu Z; Twomey C; Liu P; Castilho RM; Amelio AL
    Oral Oncol; 2021 Apr; 115():105166. PubMed ID: 33581505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
    Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
    Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
    Ahn MY; Ahn JW; Kim HS; Lee J; Yoon JH
    Oncol Rep; 2015 Apr; 33(4):1899-907. PubMed ID: 25647264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
    Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
    Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
    Zhang L; Zhang Y; Mehta A; Boufraqech M; Davis S; Wang J; Tian Z; Yu Z; Boxer MB; Kiefer JA; Copland JA; Smallridge RC; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Apr; 6(11):9073-85. PubMed ID: 25940539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.
    Wagner VP; Martins MD; Martins MAT; Almeida LO; Warner KA; Nör JE; Squarize CH; Castilho RM
    Sci Rep; 2018 Feb; 8(1):2065. PubMed ID: 29391537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.
    Lujan B; Hakim S; Moyano S; Nadal A; Caballero M; Diaz A; Valera A; Carrera M; Cardesa A; Alos L
    Br J Cancer; 2010 Aug; 103(4):510-6. PubMed ID: 20664595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
    Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.
    Lee H; Roh JL; Choi YJ; Choi J; Cho KJ
    Head Neck Pathol; 2020 Sep; 14(3):822-827. PubMed ID: 31535311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
    Ma L; Bian X; Lin W
    J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular landscape of breast mucoepidermoid carcinoma.
    Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
    Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.
    Cao W; Yao S; Li A; Chen H; Zhang E; Cao L; Zhang J; Hou Y; Dai Z; Chen J; Huang X; Yang L; Cai Z
    J Zhejiang Univ Sci B; 2023 May; 24(5):442-454. PubMed ID: 37190893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.
    Cai X; Zhai HX; Wang J; Forrester J; Qu H; Yin L; Lai CJ; Bao R; Qian C
    J Med Chem; 2010 Mar; 53(5):2000-9. PubMed ID: 20143778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of epithelial cell adhesion molecule (EpCAM) in mucoepidermoid carcinoma compared to normal salivary gland tissues.
    Kamal NM; Salem HM; Dahmoush HM
    Arch Oral Biol; 2017 Jul; 79():87-94. PubMed ID: 28347886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics and tumor microenvironment of breast mucoepidermoid carcinoma based on whole-exome and RNA sequencing.
    Ge Y; Lin X; He J; Chen W; Lin D; Zheng Y; Yang L; Xu F; Li Z
    Diagn Pathol; 2024 Jan; 19(1):15. PubMed ID: 38243319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.